COVID-19, Flu
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Individuals 18 years of age or older who visit medical facilities with symptoms of suspected respiratory tract infection and individuals 60 years of age or older who are hospitalized with symptoms of suspected respiratory tract infection.
Exclusion criteria
Exclusion criteria: Those refusing to participate in the study Those with an unknown history of COVID-19 vaccination and an unknown history of flu vaccination
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The effectiveness of COVID-19 vaccine and flu vaccine will be assessed using a test-negative design case-control study (partially using a case-control study) in individuals 18 years of age or older who visit medical facilities with symptoms of suspected respiratory tract infection and in individuals 60 years of age or older who are hospitalized with symptoms of suspected respiratory tract infection. | — |
Countries
Japan
Contacts
Institute of Tropical Medicine, Nagasaki University Department of Respiratory Infections